SIRT7 catalyzes the desuccinylation of PRMT5, thereby augmenting its methyltransferase activity and inhibiting its ubiquitination [50], thereby promoting lipid metabolic reprogramming, tumor growth, and tumor metastasis in HCC. Here, SIRT7 is linked to hepatocellular carcinoma.